Preview

Педиатрическая фармакология

Расширенный поиск

Эпидемиология, характеристика и влияние COVID-19 на детей, подростков и беременных женщин

https://doi.org/10.15690/pf.v17i4.2168

Полный текст:

Аннотация

Эта статья была ранее опубликована на английском языке. Irfan O, Tang K, Arii M, Bhutta ZA. Epidemiology, Spectrum, and Impact of COVID-19 on Children, Adolescents, and Pregnant Women. Joint IPA-UNICEF COVID-19 Information Brief, June 29, 2020. Avalaible online: https://www.unicef.org/bulgaria/sites/unicef.org.bulgaria/files/2020-07/UNICEF-IPA_COVID_brief_WEB_29June_ENG.pdf. Accessed on: September 7, 2020.

Об авторах

О. Ирфан
Центр Всемирной Охраны Здоровья Детей, Детская больница
Канада
Торонто


К. Танг
Центр Всемирной Охраны Здоровья Детей, Детская больница; Школа общественного здравоохранения Ванке, Университет Цинхуа
Канада

Торонто, Канада; 

Пекин, Китай



М. Арии
UNICEF
Соединённые Штаты Америки

Нью-Йорк



З. А. Бхутта
Центр Всемирной Охраны Здоровья Детей, Детская больница; Институт Всемирной Охраны Здоровья и Развития, Университет Ага-хана
Канада

Торонто, Канада;

Южно-центральная Азия, Восточная Африка и Великобритания



Список литературы

1. WHO. Coronavirus disease (COVID-19) outbreak situation. Avalaible online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed on: September 7, 2020.

2. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard 2020. Available online: https://covid19.who.int/. Accessed on: September 7, 2020.

3. World Health Organization. Coronavirus disease (COVID-19) Situation Report - 162 2020 [cited 2020 29 June]. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200629-covid-19-sitrep-161.pdf?sfvrsn=74fde64e_2. Accessed on: September 7, 2020.

4. Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145 (6):e20200702. doi: 10.1542/peds.2020-0702.

5. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children — United States, February 12 – April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422–426. doi: 10.15585/mmwr.mm6914e4.

6. European Centre for Disease Prevention and Control. COVID-19 cases 2020. Available online: https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html. Accessed on: September 7, 2020.

7. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270.

8. World Health Organization. Key Messages and Actions for COVID-19 Prevention and Control in Schools 2020 [cited 2020 25 June]. Available online: https://www.who.int/docs/default-source/coronaviruse/key-messages-and-actions-for-covid-19-prevention-and-control-in-schools-march-2020.pdf?sfvrsn=baf81d52_4. Accessed on: September 7, 2020.

9. Irfan O, Tang K, Lassi Z, Bhutta Z. Systematic review of clinical characteristics, treatment modalities and outcomes of SARS-Cov-2 infection in newborns, infants, children and adolescents as per the infection severity. Systematic Review in progress. PROSPERO. International prospective register of systematic reviews. 2020;CRD42020183134. Available online: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020183134.2020. Accessed on: September 7, 2020.

10. Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-1665. doi: 10.1056/NEJMc2005073.

11. Posfay-Barbe KM, Wagner N, Gauthey M, et al. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics. 2020;146(2):e20201576. doi: 10.1542/peds.2020-1576.

12. National Centre for Immunisation Research and Surveillance (NCIRS). COVID-19 in schools — the experience in NSW. 2020. Available online: http://ncirs.org.au/sites/default/files/2020-04/NCIRS%20NSW%20Schools%20COVID_Summary_FINAL%20public_26%20April%202020.pdf. Accessed on: September 7, 2020.

13. Danis K, Epaulard O, Bénet T, et al. Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clin Infect Dis. 2020;71(15):825–832. doi: 10.1093/cid/ciaa424.

14. Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205–1211. doi: 10.1038/s41591-020-0962-9. 2020.

15. Monteleone PA, Nakano M, Lazar V, et al. A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments. JBRA Assist Reprod. 2020;24(2):219. doi: 10.5935/1518-0557.20200030.

16. Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020;150(1):47–52. doi: 10.1002/ijgo.13182.

17. Lassi Z, Ali A, Das J, et al. A systematic analysis of pregnant women with COVID-19: clinical presentation, and pregnancy and neonatal outcomes as per COVID-19 severity. Systematic Review in progress. PROSPERO. International prospective register of systematic reviews. 2020;CRD42020182048 Available online: https://www.crd.york.ac.uk/prospero/display_record. php?ID=CRD42020182048. Accessed on: September 7, 2020.

18. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1–111.e14. doi: 10.1016/j.ajog.2020.04.014.

19. Chen L, Li Q, Zheng D, et al. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. N Engl J Med. 2020;382(25):e100. doi: 10.1056/NEJMc2009226. 2020.

20. Juan J, Gil MM, Rong Z, et al. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review. Ultrasound Obstet Gynecol. 2020;56(1):15–27. doi: 10.1002/uog.22088.

21. Penfield C BS, Limaye M et al. . Detection of severe acute respiratory syndromecoronavirus 2 in placental and fetal membranesamples. Am J Obstet Gynecol MFM. 2020;2(3):100133. doi: 10.1016/j.ajogmf.2020.100133.

22. Patanè L, Morotti D, Giunta MR, et al. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019 — positive mothers and neonates at birth. Am J Obstet Gynecol MFM. 2020;2(3):100145. doi: 10.1016/j.ajogmf.2020.100145.

23. Dumpa V, Kamity R, Vinci AN, et al. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature. Cureus. 2020;12(5):e8165. doi: 10.7759/cureus.8165.

24. Groß R, Steinhart K, Kirchhoff F, Münch J. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020;395(10239):1757-1758. doi: 10.1016/ S0140-6736(20)31181-8.

25. World Health Organization. Clinical management of COVID-19: Interim guidance, May 27, 2020. Available online: https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed on: September 7, 2020.

26. Jones TC, Mühlemann B, Veith T, et al. An analysis of SARS-CoV-2 viral load by patient age. German Research network Zoonotic Infectious Diseases website. 2020. doi: 10.1101/2020.06.08.20125484.

27. Lu Y, Li Y, Deng W, et al. Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan. Pediatr Infect Dis J. 2020;39(7):e95–e99. doi: 10.1097/INF.0000000000002729.

28. Parri N, Lenge M, Buonsenso D. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020; 383(2):187–190. doi:10.1056/NEJMc2007617.

29. de Souza TH, Nadal JA, Nogueira RJ, et al. Clinical Manifestations of Children with COVID-19: a Systematic Review. Pediatr Pulmonol. 2020;55(8):1892–1899. doi: 10.1002/ppul.24885.

30. Chen A, Huang J, Liao Y, et al. Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults. Radiol Cardiothorac Imag. 2020;2(2):e200117. doi: 10.1148/ryct.2020200117.

31. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020 May 11. Online ahead of print. doi:10.1001/jamapediatrics.2020.1948.

32. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children. Intensive Care Med. 2020;46(Suppl 1):10–67. doi: 10.1007/s00134-019-05878-6.

33. Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582(7813):469. doi: 10.1038/d41586-020-01824-5.

34. WHO. News release: WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients. 2020. Available online: https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexametha-sone-use-in-treating-critically-ill-covid-19-patients. Accessed on: September 7, 2020.

35. Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608. doi: 10.1016/S0140-6736(20)31094-1.

36. European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children — 15 May 2020. ECDC: Stockholm; 2020.

37. CDC U. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C). Available online: https://www.cdc.gov/mis-c/hcp. Accessed on: September 7, 2020.

38. Rauf A, Vijayan A, John ST, et al. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic. Indian J Pediatr. 2020;87(9):745–747. doi: 10.1007/s12098-020-03357-1.

39. Balasubramanian S, NagendranT M, Ramachandran B, Ramanan AV. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully with Intravenous Immunoglobulin and Tocilizumab. Indian Pediatr. 2020;57(7):681–683. doi: 10.1007/s13312-020-1901-z.

40. Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020 Jun 8;e2010369. Online ahead of print. doi: 10.1001/jama.2020.1036.

41. CDC U. Severe outcomes among patients with COVID-19 — United States, Feb 12 – March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–346. doi: 10.15585/mmwr.mm6912e2.

42. WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19: Scientific brief, May 15, 2020. Available online: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on: September 7, 2020.

43. Health RCoPaC. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS). 2020. Available online: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammato-ry%20syndrome-20200501.pdf. Accessed on: September 7, 2020.

44. WHO. Global COVID-19 clinical platform: case report form for suspected cases of multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19. May 18, 2020. Available online: https://apps.who.int/iris/bitstream/handle/10665/332121/WHO-2019-nCoV-MIS_Children_CRF-2020.1-eng.pdf. Accessed on: September 7, 2020.

45. UN. Policy Brief: The Impact of COVID-19 on children. April 15, 2020. Available online: https://unsdg.un.org/sites/default/files/2020-04/160420_Covid_Children_Policy_Brief.pdf. Accessed on: September 7, 2020.

46. UNICEF. COVID-19: Number of children living in household poverty to soar by up to 86 million by end of year. May 27, 2020. Available online: https://www.unicef.org/press-releases/covid-19-number-children-living-household-poverty-soar-86-million-end-year. Accessed on: September 7, 2020.

47. UNESCO. Education: From disruption to recovery. Available online: https://en.unesco.org/covid19/educationresponse. Accessed on: September 7, 2020.

48. Programme WF. 2020 – Global Report on Food Crises. April 20, 2020. Available online: https://docs.wfp.org/api/documents/WFP-0000114546/download/?_ga=2.26030910.203248295.1599480598-439563952.1599480598.pdf. Accessed on: September 7, 2020.

49. Viner RM, Russell SJ, Croker H, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. Lancet Child Adolesc Health. 2020;4(5):397–404. doi: 10.1016/S2352-4642(20)30095-X.

50. Roberton T, Carter ED, Chou VB, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(7):e901–e908. doi: 10.1016/S2214-109X(20)30229-1.

51. WHO. At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF: News release, May 22, 2020. Available online: https://www.who.int/news-room/detail/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef. Accessed on: September 7, 2020.

52. UNICEF. More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges: Statement by the Measles & Rubella Initiative: American Red Cross, U.S. CDC, UNICEF, UN Foundation and WHO, April 13, 2020. Available online: https://www.unicef.org/press-releases/more-117-million-children-risk-missing-out-measles-vaccines-covid-19-surges. Accessed on: September 7, 2020.

53. Klein JD, Koletzko B, El-Shabrawi MH, et al. Promoting and supporting children’s health and health-care during COVID-19 — International Paediatric Association Position Statement. Arch Dis Child. 2020;105(7):620–624. doi: 10.1136/ archdischild-2020-319370.

54. WHO. Considerations for school-related public health mea-sures in the context of COVID-19: Annex to Considerations in adjusting public health and social measures in the context of COVID-19, May 10, 2020. Available online: https://www.who.int/publications/i/item/considerations-for-school-related-public-health-measures-in-the-context-of-covid-19. Accessed on: September 7, 2020.

55. UNICEF, WHO, IFRC. Interim Guidance for COVID-19 Prevention and Control in Schools. Marth, 2020. Available online: https://www.unicef.org/media/66216/file/Key%20Messages%20and%20Actions%20for%20COVID-19%20Prevention%20and%20Control%20in%20Schools_March%202020.pdf. Accessed on: September 7, 2020.

56. UNICEF. Framework for Reopening Schools: From UNESCO, UNICEF, the World Bank, the World Food Programme and UNHCR, June, 2020. Available online: https://www.unicef.org/media/71366/file/Framework-for-reopening-schools-2020.pdf. Accessed on: September 7, 2020.


Для цитирования:


Ирфан О., Танг К., Арии М., Бхутта З.А. Эпидемиология, характеристика и влияние COVID-19 на детей, подростков и беременных женщин. Педиатрическая фармакология. 2020;17(4):352-359. https://doi.org/10.15690/pf.v17i4.2168

For citation:


Irfan O., Tang K., Arii M., Bhutta Z.A. Epidemiology, Spectrum, and Impact of COVID-19 on Children, Adolescents, and Pregnant Women. Pediatric pharmacology. 2020;17(4):352-359. (In Russ.) https://doi.org/10.15690/pf.v17i4.2168

Просмотров: 145


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)